EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia

ESMO expert consensus statements on the management of EGFR mutant Non-Small Cell Lung Cancer

(2022) A. Passaro et al.   ANNALS OF ONCOLOGY

Malignant pleural effusions for cancer genotyping: A matter of trans-pleural traffic of cell-free tumor DNA

(2022) Gábor Méhes et al.   MOLECULAR AND CELLULAR PROBES

Cytology–Based Specimen Triage for Epidermal Growth Factor Receptor Mutation Testing of Malignant Pleural Effusions in Non–Small Cell Lung Cancer

(2022) Chi-Lu Chiang et al.   Frontiers in Oncology

Real-World Patient Characteristics, Treatment Patterns, and Mutation Testing Patterns Among US Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations

(2022) Jinghua He et al.   ADVANCES IN THERAPY

Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma

(2022) Vera Jokic et al.   Dose-Response

Lung Cancer in Serbia

(2022) Milena Cavic et al.   Journal of Thoracic Oncology

EGFR testing in paraffin-embedded cell block cytology material is reliable with increased detection for effusion fluid

(2022) Joanna Ka Man Ng et al.   LUNG CANCER

Up-front mutation detection in circulating tumor DNA by droplet digital PCR has added diagnostic value in lung cancer

(2022) Esther Visser et al.   Translational Oncology

Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience

(2022) Michelle Chen et al.   Journal of Personalized Medicine

Hematological parameters in EGFR-mutated advanced NSCLC patients treated with TKIs: predicting survival and toxicity

(2021) Vera Jokic et al.   Expert Review of Anticancer Therapy

Screening for lung cancer in individuals who never smoked: An IASLC Early Detection and Screening Committee Report

(2021) Anna Kerpel-Fronius et al.   Journal of Thoracic Oncology

Cytologic Investigations for the Diagnosis of Malignant Pleural Effusion in Non–small Cell Lung Cancer

(2021) Samira Shojaee et al.   Journal of Bronchology & Interventional Pulmonology

A multicenter real-world study of tumor-derived DNA from pleural effusion supernatant in genomic profiling of advanced lung cancer

(2020) Shidai Jin et al.   Translational Lung Cancer Research

Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals

(2020) Milena Cavic et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR

(2020) Annamaria Siggillino et al.   Diagnostics

Prognostic impact of pleural effusion in EGFR -mutant non-small cell lung cancer patients without brain metastasis

(2019) Akihiro Yoshimura et al.   Thoracic Cancer

Prospective detection of mutations in cerebrospinal fluid, pleural effusion and ascites of advanced cancer patients to guide treatment decisions

(2019) Sergio Villatoro et al.   Molecular Oncology

Detection of EGFR gene mutation status from pleural effusions and other body fluid specimens in patients with lung adenocarcinoma

(2019) Ping Zhang et al.   Thoracic Cancer

Next generation sequencing-based molecular profiling of lung adenocarcinoma using pleural effusion specimens

(2018) Liping Liu et al.   Journal of Thoracic Disease

A comparison of QuantStudio™ 3D Digital PCR and ARMS-PCR for measuring plasma EGFR T790M mutations of NSCLC patients

(2018) Qin Feng et al.   Cancer Management and Research

TP53 and DNA-repair gene polymorphisms genotyping as a low-cost lung adenocarcinoma screening tool

(2018) Milena Cavic et al.   JOURNAL OF CLINICAL PATHOLOGY

EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study

(2017) Baohui Han et al.   LUNG CANCER

Cell-free DNA: Treasure trove for cancer medicine

(2017) Miljana Tanić et al.   NATURE MATERIALS

Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer

(2017) Tony S. Mok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

(2015) James Chih-Hsin Yang et al.   LANCET ONCOLOGY

Clinical features and survival of lung cancer patients with pleural effusions

(2015) Jose M. Porcel et al.   RESPIROLOGY

EGFR Mutations in Asian Patients with Advanced Lung Adenocarcinoma

(2014) Chong-Kin Liam et al.   Journal of Thoracic Oncology

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors

(2013) Neal I. Lindeman et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Liquid biopsy: monitoring cancer-genetics in the blood

(2013) Emily Crowley et al.   Nature Reviews Clinical Oncology

Pleural Effusion in Lung Cancer: More Questions than Answers

(2012) Marios E. Froudarakis   RESPIRATION

Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010

(2010) C. Hooper et al.   THORAX